NF-kappaB tumorigenesis and drug developement.
- Author:
Wei-Feng LIU
1
;
Shan-Shan YU
;
Yue-Zhong LI
Author Information
1. State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Jinan 250100, China. weifliu@sdu.edu.cn
- Publication Type:Journal Article
- MeSH:
Animals;
Drug Evaluation, Preclinical;
Humans;
I-kappa B Proteins;
metabolism;
NF-kappa B;
antagonists & inhibitors;
metabolism;
physiology;
Neoplasms;
etiology;
Signal Transduction;
Transcription, Genetic;
physiology
- From:
Chinese Journal of Biotechnology
2005;21(1):12-18
- CountryChina
- Language:Chinese
-
Abstract:
NF-kappaB, a collective name of dimeric transcription factors, is composed of members of the Rel family proteins that recognize and bind a specific DNA sequence. It is normally sequestered in the cytoplasm of non-stimulated cells by associating with a family of inhibitor proteins called IkappaBs. Exposure of cells to a variety of extra-and intra-cellular stimuli leads to the rapid proteolytic degradation of IkappaBs, which frees NF-kappaBs allowing them to translocate to the nucleus where it regulates gene transcription. NF-kappaB is involved in a lot of physiological processes such as immunity, inflammation, cell proliferation, apoptosis and even tumorigenesis by regulating the transcription of a larger number of genes. This review introduces the various mechanisms of NF-kappaB activation including a recently reported alternative activation pathway mediated by lymphotoxin alpha/beta, B cell activating factor and CD40 ligand. The signal transduction pathway leading to NF-kappaB activation via IKK in response to proinflammatory factors like TNF-alpha and IL-1 is addressed in more detail concerning the regulation of IKK activity, mechanism of IkappaB degradation and regulation of transactivation activity of NF-kappaB on different levels. Considering the important role of NF-kappaB in cell proliferation and regulation of various genes participating in apoptosis, the involvement of NF-kappaB in tumorigenesis and drug screening is also discussed.
